StairMed lately accomplished a $72.5 million strategic financing spherical, led by Alibaba with co-investment from SDIC Innovation Capital. Present traders together with Tencent, Origin Capital, Aobo Capital, Yuanhe Origin, Qiming Enterprise Companions, Lilly Asia Ventures, Supply Code Capital, and Shanghai SDIC Main Fund additionally participated. Qifeng Capital acted because the unique monetary advisor. Within the earlier spherical, Supply Code Capital and Shanghai SDIC Main Fund served as joint lead traders.
Notably, StairMed has raised over $160 million in whole funding inside the previous yr, changing into the primary brain-machine interface (BMI) firm invested in by each Alibaba and Tencent.
Superior Mind-Machine Interface Know-how
Based in 2021, StairMed focuses on minimally invasive implantable BMIs and has developed a number of world-leading applied sciences, spanning electrodes, techniques, algorithms, and surgical robotics. The corporate’s R&D covers two important enterprise traces: brain-control purposes and neuromodulation therapies, aiming to supply progressive options for sufferers with motor issues and neurological ailments.
Key technological breakthroughs embrace:
- Extremely-flexible electrodes with a diameter 1/100 the thickness of a human hair.
- World’s smallest wi-fi brain-machine implant, enabling China’s first potential medical trial of invasive BMIs in 2025.
Scientific Milestones and 256-Channel Breakthrough
Following the profitable completion of three BMI medical trials in 2025, StairMed’s medical progress continues to speed up. In early 2026, utilizing proprietary surgical robotics, the corporate efficiently implanted its 256-channel Wi-fi Excessive-Throughput Invasive BMI System (WRS02). The process demonstrated efficient brain-control interplay, marking the primary 256-channel invasive BMI medical trial in China.
The WRS02 system can be the one invasive BMI system in China permitted for the Nationwide Medical Merchandise Administration’s “inexperienced channel” for progressive medical gadgets, representing a revolutionary step in high-performance invasive BMIs.
StairMed plans to launch a large-scale, multi-center registration medical trial in mid-2026, concentrating on roughly 40 sufferers inside the yr. By the tip of 2026, whole medical implantations might method and even surpass Neuralink’s present trial depend of 21 sufferers, signaling China’s fast march towards world management in commercialized BMI options.
Increasing into Neuromodulation
Alongside brain-control product medical deployment, StairMed is actively growing neuromodulation therapies. Leveraging globally main ultra-flexible microelectrode know-how, which rivals or surpasses Neuralink in miniaturization and softness, the corporate has developed a closed-loop, ultra-low trauma deep mind stimulation system.
- The system received first prize within the 2025 Nationwide Disruptive Know-how Innovation Competitors, Mind-Machine Methods class.
- 4 medical analysis implantations have already validated its purposeful efficacy.
- Plans are underway to start full medical trials in 2027, concentrating on ailments similar to Parkinson’s and epilepsy, providing probably transformative therapies.
These achievements spotlight StairMed’s complete strategic worth within the world BMI discipline.
Strategic Significance of Tech Large Partnerships
Li Xue, founding father of StairMed, emphasised the milestone significance of deep involvement from main tech corporations:
“BMIs are usually not solely cutting-edge medical know-how but additionally the final word convergence of life sciences and data know-how. The expertise of tech giants in multimodal AI fashions, computing infrastructure, sensible {hardware}, and ecosystem deployment can deeply combine with StairMed’s globally main BMI {hardware} and medical translation experience. This robust collaboration will drive the following technology of clever BMI techniques and a wealthy frontier utility ecosystem, supporting medical innovation whereas laying the groundwork for future human-computer interplay capabilities.”
Supply: IPOzaozhidao
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a worldwide community of future-focused thinkers.
Unlock tomorrow’s developments in the present day: learn extra, subscribe to our e-newsletter, and turn out to be a part of the NextTech neighborhood at NextTech-news.com
